Results 141 to 150 of about 8,911,089 (208)

Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta-analysis. [PDF]

Biomed Rep
Li Y, Lv C, Cao L, Lihua S, Ma Y.
europepmc   +1 more source

Coronary Microvascular Dysfunction and Major Adverse Cardiovascular Events in Patients With Ischemia and Non-obstructive Coronary Arteries: A Systematic Review. [PDF]

Cureus
Abdallah OW, Attia F, Al-Saleh GM, Alaqabawi A, Mustafa MA, Difallah Al Darawsheh A, Abuhalaweh N, Allasasmeh MO, Al-Samarat ZA, Somrain L, Abuali R.   +10 more
europepmc   +1 more source

Circulating musclin as a potential prognostic biomarker for major adverse cardiovascular events in surgically treated acute aortic dissection: a retrospective cohort study. [PDF]

Front Cardiovasc Med
Liu J, Liu Z, Guo L, Wang Z, Wu J, Li X, Zhang H, Liu H.   +7 more
europepmc   +1 more source

2024-2025 COVID-19 Vaccine and Major Adverse Cardiovascular Events Among US Veterans.

JAMA Intern Med
Cai M, Xie Y, Al-Aly Z.
europepmc   +1 more source

<i>LUCAT1</i> Links Interferon Signaling in Platelets to Major Adverse Cardiovascular Events. [PDF]

Arterioscler Thromb Vasc Biol
van Solingen C, Muller MA, Sowa MA, Barrett TJ.   +3 more
europepmc   +1 more source

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis. [PDF]

Lancet HIV
Umbleja T, Zafar MU, McCallum S, Gattu AK, Zanni MV, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Currier JS, Sponseller CA, Diggs MR, Chu SM, Lu AB, Glesby MJ, Stapleton JT, Frank M, Nguyen KL, Bender Ignacio RA, Han WM, Douglas PS, Aberg JA, Ribaudo HJ, Grinspoon SK.   +22 more
europepmc   +1 more source

Systemic Sclerosis-Specific Determinants of Major Adverse Cardiovascular Events: Development of an Exploratory Cardiovascular Risk Model Beyond Traditional Risk Factors. [PDF]

Diagnostics (Basel)
Groseanu ML, Rusu VA.
europepmc   +1 more source

Residual lipid-related proteomic and metabolomic signatures associated with major adverse cardiovascular events after revascularization in peripheral artery disease. [PDF]

BMC Cardiovasc Disord
Cao S, Zhang B, Li P, Luo J, Tan S, Lu C, Yu F, Yang C, Chen Z, Li Y, Diao Y.   +10 more
europepmc   +1 more source

Discovery and validation of a multi-protein panel for predicting non-fatal major adverse cardiovascular events in diabetic kidney disease. [PDF]

Front Endocrinol (Lausanne)
Jiang L, Chien C, Li T, Zhang H, Zhao T, Wu X.   +5 more
europepmc   +1 more source